{
    "nct_id": "NCT03980041",
    "official_title": "A Phase 2, Multicenter, Randomized, Double-Blind, Active-Control Study to Evaluate the Efficacy and Safety of Nivolumab Administered in Combination With IPI-549 Compared to Nivolumab Monotherapy in the Treatment of Patients With Immune Therapy-Naïve, Advanced Urothelial Carcinoma",
    "inclusion_criteria": "* Histologically or cytologically confirmed urothelial carcinoma of the renal pelvis, ureter, bladder, or urethra\n* Measurable disease by CT or MRI as defined by RECIST v1.1\n* Disease progression or recurrence after treatment:\n* i) With at least 1 platinum-based chemotherapy regimen for the treatment of metastatic (Stage IV) or locally advanced unresectable disease; or\n* ii) With disease recurrence within 1 year of completing a platinum-based neoadjuvant or adjuvant therapy\n* Subject that have received more than 2 prior lines of chemotherapy must not have liver metastases\n* Tumor tissues (archived or new biopsy) must be provided for biomarker analysis\n* Eastern Cooperative Oncology Group (ECOG) performance status ≤1\n* Blood sample must be provided for mMDSC levels for randomization into the study\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Active brain metastases or leptomeningeal metastases\n* Any serious or uncontrolled medical disorder that may interfere with study treatment/interpretation\n* Prior malignancy active within the previous 3 years except for local or organ confined early stage cancer that has been apparently cured\n* Active, known, or suspected autoimmune disease\n* A condition requiring systemic treatment with either corticosteroids (>10 mg daily prednisone equivalents) or other immunosuppressive medications within 14 day of study drug administration\n* Prior therapy with anti-tumor vaccines, any T cell co-stimulation or checkpoint pathways, or IPI-549\n* Prior surgery or gastrointestinal dysfunction that may affect drug absorption\n* Past medical history of interstitial lung disease\n* History of stroke, unstable angina, myocardial infarction, or ventricular arrhythmia requiring medication or mechanical control\n* Positive test for hepatitis B, C or HIV\n* Dependent on continuous supplemental oxygen",
    "miscellaneous_criteria": ""
}